DIGITALDX
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video
Picture
Jerry Lanchbury, JD
Picture
  • Chief Scientific Officer — Myriad Genetics
  • Executive VP —Myriad Genetics
  • SVP Rearch — Myriad Genetics
  • Reader in Molecular Immunogenetics and Head of Molecular Genetics — GKT School of Medicine, King’s College London
  • PhD, Human Population Genetics, Newcastle University
At Myriad Genetics, Jerry Lanchbury led teams that were responsible for major molecular diagnostic innovations across the areas of oncology, urology, rheumatology and neuroscience. Proven track record in molecular genetic discovery, clinical product ideation and translation into high value clinical and companion diagnostics. Discoveries ranged across cancer prognostics, cancer genetic predisposition tests, rheumatoid arthritis disease activity and prognosis and cardiovascular disease risk prediction. Notable field transforming products included myChoice HRD for PARP inhibitors, BracAnalysis CDX for PARP inhibitors, Prolaris, myPlan Lung, myRisk, Riskscore for all ancestries, Vectra and Vectra cardiovascular. 

Prior to Myriad Genetics, Lanchbury was a Strateigeic Advisor to Gemini Genomics, Director of Dunhill Medical Research Laboratories, Senior Lecturer in Molecular Immunogenetics, Division of Medicine at United Medical and Dental Schools of Guys and St. Thomas Hospitals, and Deputy Director of Clinical Science Laboratories at United Medical and Dental Schools of Guys and St. Thomas Hospitals.
​

Jerry earned his BSC (Hons) Biology from Aston University and PhD in Human Population Genetics from Newcastle University.
Disclaimer
Terms & Conditions
Privacy Policy
Investment Inquiries
Contact
Picture
Picture
Picture
 Copyright © 2022 All Rights Reserved
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video